All updates

All updates

icon
Filter
Funding
LEVY Health raises USD 2.8 million in funding
Fertility Tech
Mar 30, 2022
Last week:
Funding
Moment Energy secures USD 20.3 million in government funding from US Department of Energy
Alternative Energy
Dec 28, 2024
Funding
Fluence Energy raises USD 300 million in convertible notes to upgrade battery production
Alternative Energy
Dec 28, 2024
M&A
Coralogix acquires AI observability platform Aporia for USD 50 million
Generative AI Infrastructure
Dec 23, 2024
Product updates
Pimax announces compact Dream Air VR headset for USD 1,900
Extended Reality
Dec 23, 2024
Funding
HuLoop raises Series A funding from Mighty Capital
Workflow Automation Platforms
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
Financial Wellness Tools
Dec 23, 2024
M&A
Fiserv to acquire Payfare for undisclosed sum to enhance embedded finance solutions
FinTech Infrastructure
Dec 23, 2024
Funding
Meight raises EUR 3.4 million in funding led by Cusp Capital
Smart Mobility Information
Dec 23, 2024
Regulation/policy
Desktop Metal sues Nano Dimension over merger compliance
Additive Manufacturing
Dec 23, 2024
Management news
Nexa3D scales back operations amid financial crisis
Additive Manufacturing
Dec 23, 2024
Fertility Tech

Fertility Tech

Mar 30, 2022

LEVY Health raises USD 2.8 million in funding

Funding

  • LEVY Health, a digital platform for fertility medicine, has raised USD 2.8 million (EUR 2.5 million) in a funding round led by Atlantic Labs with participation from Calm Storm and several angel investors (60% women) including Lea von Bidder (AVA), Jenny Saft (OVIAVO), Hansi Hansmann, and Marie-Sophie von Bibra (Readly).

  • Founded in 2020, LEVY Health is a female-led company that claims to be the first in the world to have developed a licensed (CE-compliant) medical software. LEVY Fertility Code analyzes fertility disorders in women and provides precision fertility diagnostics and personalized therapy recommendations to support the decision-making process for patients and gynecologists in the shortest possible time. LEVY Fertility Code leverages proprietary algorithms and clinical guidelines from the EU and US to reduce time for fertility diagnosis and therapy from 4–5 years to just two months. The software has been available in Germany since the end of January 2022.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.